EstechPharma Co. Ltd (041910) — Capital Reinvestment Ratio
Latest as of December 2025:
0.00x
EstechPharma Co. Ltd (041910) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩2.38 Billion) in capital expenditures (₩11.20 Million). See EstechPharma Co. Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
₩2.38 Billion
KRW
Capital Expenditures
₩11.20 Million
KRW
Data as of
Dec 2025
Most recent filing
EstechPharma Co. Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks EstechPharma Co. Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for EstechPharma Co. Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for EstechPharma Co. Ltd from 2013 to 2025. For live market cap and broader valuation context, see market value of EstechPharma Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | ₩8.83 Billion | ₩554.56 Million | ▼ -90.9% |
| 2024 | 0.69x | ₩7.93 Billion | ₩5.45 Billion | ▲ +221.9% |
| 2023 | 0.21x | ₩4.79 Billion | ₩1.02 Billion | ▼ -93.6% |
| 2021 | 3.31x | ₩603.42 Million | ₩2.00 Billion | ▲ +609.2% |
| 2020 | 0.47x | ₩4.71 Billion | ₩2.20 Billion | ▲ +78.0% |
| 2019 | 0.26x | ₩4.29 Billion | ₩1.13 Billion | ▲ +308.1% |
| 2018 | 0.06x | ₩7.25 Billion | ₩466.07 Million | ▼ -35.0% |
| 2017 | 0.10x | ₩6.99 Billion | ₩691.73 Million | ▼ -61.2% |
| 2016 | 0.26x | ₩8.19 Billion | ₩2.09 Billion | ▼ -44.4% |
| 2015 | 0.46x | ₩10.46 Billion | ₩4.80 Billion | ▲ +85.5% |
| 2014 | 0.25x | ₩4.99 Billion | ₩1.24 Billion | ▲ +72.2% |
| 2013 | 0.14x | ₩10.19 Billion | ₩1.47 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow